FDA criticizes Lundbeck for webpages on migraine treatment Vyepti

July 9, 2026 01:50 PM EDT FDA+ FDA crit­i­cizes Lund­beck for now-delet­ed web­pages pro­mot­ing its mi­graine treat­ment Zachary Brennan Senior Editor The FDA has chas­tised Lund­beck Seat­tle Bio­phar­ma­ceu­ti­cals for two pro­mo­tion­al web­pages, nei­ther of which is still on­line, that made al­leged­ly in­flat­ed claims re­gard­ing the ef­fi­ca­cy … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER